Follow
Gavin Johnson
Gavin Johnson
Texas A&M Health Science Center
Verified email at ibt.tamhsc.edu
Title
Cited by
Cited by
Year
Long noncoding RNAs and sulforaphane: a target for chemoprevention and suppression of prostate cancer
LM Beaver, R Kuintzle, A Buchanan, MW Wiley, ST Glasser, CP Wong, ...
The Journal of nutritional biochemistry 42, 72-83, 2017
932017
Nrf2 status affects tumor growth, HDAC3 gene promoter associations, and the response to sulforaphane in the colon
P Rajendran, WM Dashwood, L Li, Y Kang, E Kim, G Johnson, KA Fischer, ...
Clinical epigenetics 7, 1-12, 2015
612015
Heterocyclic analogs of sulforaphane trigger DNA damage and impede DNA repair in colon cancer cells: interplay of HATs and HDACs
A Okonkwo, J Mitra, GS Johnson, L Li, WM Dashwood, ML Hegde, C Yue, ...
Molecular nutrition & food research 62 (18), 1800228, 2018
572018
A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane‐treated colon cancer cells
GS Johnson, J Li, LM Beaver, WM Dashwood, D Sun, P Rajendran, ...
Molecular nutrition & food research 61 (4), 1600769, 2017
452017
Acetylation of CCAR2 establishes a BET/BRD9 acetyl switch in response to combined deacetylase and bromodomain inhibition
P Rajendran, G Johnson, L Li, YS Chen, M Dashwood, N Nguyen, ...
Cancer research 79 (5), 918-927, 2019
362019
Reciprocal regulation of BMF and BIRC5 (Survivin) linked to Eomes overexpression in colorectal cancer
R Wang, Y Kang, CV Löhr, KA Fischer, CS Bradford, G Johnson, ...
Cancer letters 381 (2), 341-348, 2016
252016
CCAR1 and CCAR2 as gene chameleons with antagonistic duality: Preclinical, human translational, and mechanistic basis
GS Johnson, P Rajendran, RH Dashwood
Cancer Science 111 (10), 3416-3425, 2020
242020
p53-dependent autophagic degradation of TET2 modulates cancer therapeutic resistance
J Zhang, P Tan, L Guo, J Gong, J Ma, J Li, M Lee, S Fang, J Jing, ...
Oncogene 38 (11), 1905-1919, 2019
182019
CCAR2 acetylation establishes a BET/BRD9 acetyl switch in response to combined deacetylase and bromodomain inhibition
GS Johnson, P Rajendran, L Li, YS Chen, WM Dashwood, N Nguyen, ...
Cancer Research 79 (13_Supplement), 2614-2614, 2019
2019
Expanding Epigenetic Mechanisms of Sulforaphane in Colorectal Cancer: Pseudogenes and Protein Acetylation
GS Johnson
2019
Front cover: A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane‐treated colon cancer cells
GS Johnson, J Li, LM Beaver, WM Dashwood, D Sun, P Rajendran, ...
Molecular Nutrition & Food Research 61 (4), 1770041, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–11